Presence of a metabotropic and an ionotropic purinergic receptor on rat submandibular ductal cells.
ATP (1 microM-1 mM) increased the intracellular Ca2+ concentration ([Ca2+]i) in rat submandibular ductal cells. The dose-response curve was biphasic with a first plateau approximately 10 microM and a second increase at concentrations higher than 100 microM. This second increase was abolished in the absence of extracellular calcium or in the presence of Coomassie blue and could be mimicked by benzoyl-ATP. The activation of this response increased the uptake of extracellular manganese and the release of kallikrein, a ductal cell marker. The response at low concentrations of ATP was mimicked by ADP, 2-methylthioadenosine 5'-triphosphate (2-MeS-ATP; which was the most potent agonist), adenosine 5'-O-(2-thiodiphosphate), and UTP. Removal of extracellular calcium did not abolish this response, but ADP or 2-MeS-ATP had no effect after a preincubation with thapsigargin. A preincubation with 2-MeS-ATP desensitized the receptor involved in the response to both ADP and UTP. Similarly, a pretreatment with UTP prevented a further response to ADP. ADP increased the intracellular concentration of inositol 1,4,5-trisphosphate but did not affect the secretion of kallikrein. In conclusion, rat submandibular ductal cells possess two types of purinergic receptors: a metabotropic (P2y1) receptor and a P2x ionotropic purinergic receptor coupled to a manganese-permeant calcium channel and to kallikrein secretion.
Amsallem
H
H
Department of Physiology, Corob Center for Medical Research, Faculty for Health Science, Ben-Gurion University, Beer-Sheva, Israel.
Métioui
M
M
VandenAbeele
A
A
Elyamani
A
A
Moran
A
A
Dehaye
J P
JP
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism*; D002217:Carbachol / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D066298:In Vitro Techniques; D007610:Kallikreins / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008345:Manganese / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D018048:Receptors, Purinergic P2 / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology*; D058472:Receptors, Purinergic P2Y1; D013363:Submandibular Gland / Q000166:cytology / Q000378:metabolism*; D013997:Time Factors
C546384:P2ry1 protein, rat; D018048:Receptors, Purinergic P2; D058472:Receptors, Purinergic P2Y1; D008345:Manganese; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D002217:Carbachol; D007610:Kallikreins; D002118:Calcium; D004837:Epinephrine